Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model
PharmacoEconomics - Open- Switzerland
doi 10.1007/s41669-016-0005-0
Full Text
Abstract
Available in
Date
November 16, 2016
Authors
Publisher
Springer Science and Business Media LLC